| Primary information |
|---|
| ID | 10338 |
| Uniprot ID | Q8WXF3 |
| Description | Relaxin-3 precursor (Prorelaxin H3) (Insulin-like peptide INSL7)(Insulin-like peptide 7) [Cleaved into- - Relaxin-3 B chain; Relaxin-3 Achain]. |
| Organism | Homo sapiens |
| Txonomy | Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Primates; Haplorrhini; Simiiformes; Catarrhini; Hominoidea (apes); Hominidae (great apes); Homininae; Homo; Homo sapiens (Human) |
| Subcellular Location | Secreted |
| Developmental Stage | NA |
| Similarity | Belongs to the insulin family. |
| Tissue Specificity | NA |
| Post Translational Modification | NA |
| Function | May play a role in neuropeptide signaling processes. Ligand for LGR7; relaxin-3 receptor-1 (GPCR135) and relaxin-3 receptor-2 (GPCR142). |
| Length | 142 |
| Molecular Weight | 15451 |
| Name | Relaxin-3 B chain |
| Sequence | RAAPYGVRLCGREFIRAVIFTCGGSRW |
| Sequence map | 27 (26-52) |
| PDB ID | 2FHW |
| Drugpedia | NA |
| Receptor | Q9HBX9; Q9NSD7; Q8TDU9;Q9NSD7;Q8TDU9;Q9HBX9;Q8WXD0 |
| Domain | NA |
| Pharmaceutical Use | NA
|